Cynthia Nixon talks about cancer and "Sex and the City"

Article

While there are many inspiring aspects of my job as CURE's senior managing editor, one of my favorite moments of the year is attending CURE's Extraordinary Healer Award for Oncology Nursing.

This year's event honored three outstanding nurses who went above and beyond to help their patients. But the evening also pays tribute to all oncology nurses and how they encourage and sustain those on the cancer journey. At this year's event, the mistress of ceremonies was Cynthia Nixon who is known for her role as Miranda on "Sex and the City" and for countless other characters she has portrayed in plays, movies and television. Among her many awards are Emmys, a Tony, a Grammy and Golden Globes. All this is very admirable, no doubt, but I am also impressed by Nixon's advocacy as a breast cancer survivor.

I had the opportunity to chat with Nixon for a few minutes before she went on to host the Extraordinary Healer event. She spoke openly about her breast cancer experience and shared details of her treatment. She also shared her mother's story, a two-time survivor who, after being first diagnosed with breast cancer, had to advocate for a lumpectomy over mastectomy during a time when lumpectomies were not common. And Nixon discussed the "Sex and the City" episodes in which Samantha had breast cancer.

I asked Nixon if having cancer changed her life. She said, "It's so hard to know. I got cancer the year I turned 40. Turning 40 was a big deal for me, not necessarily in a bad way. It just felt like I had arrived at a real peak in my life--that I could look forward and I could look back. I had a big party and invited people from my past, my present, and people I didn't know well but always wanted to be friends with. And I feel like the cancer only added to that feeling--that we are not going to be here forever. Are you living your life the way you want it to be? What are the things you've always wanted to do or meant to do? You're still here, and you're 40. Why aren't you doing them? It sounds small but I started taking singing lessons, things like that, that really made me put my money where my mouth was. You can't constantly defer--at some point, you have to step up."

To read the entire interview, click here. And tell us what you have "stepped up" to change in your life after cancer.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content